News | Point-of-Care Ultrasound (POCUS) | October 08, 2020

Butterfly Network Releases New Version of Point-of-Care Ultrasound Platform With Butterfly iQ+

Using ultrasound-on-chip technology the system turns a smartphone into a whole-body diagnostic imaging system

Butterfly Network Inc. is launching its next-generation Butterfly iQ+ point-of-care-ultrasound (POCUS) technology that can turn a smartphone into a diagnostic imaging system. It offers a new needle guidance app.

Butterfly Network Inc. is launching its next-generation Butterfly iQ+ point-of-care-ultrasound (POCUS) technology that can turn a smartphone into a diagnostic imaging system. It offers a new needle guidance app.


October 8, 2020 – Butterfly Network Inc. is launching its next-generation Butterfly iQ+ point-of-care-ultrasound (POCUS) technology that can turn a smartphone into a diagnostic imaging system.

Using ultrasound-on-chip technology, the Butterfly iQ+ offers new capabilities, such as faster frame rates, Needle Viz technology, a longer battery life and improved durability. 

Butterfly’s mission is to democratize healthcare by making medical imaging accessible to everyone around the world. From underserved communities in the United States, to remote areas around the globe, 4.7 billion people lack access to medical imaging. Putting ultrasound on a chip, Butterfly was able to define a new precedent of affordability by providing a whole-body ultrasound device at $1,999, plus membership. The Butterfly iQ+ will be available for the same price. 

“Two years ago, Butterfly introduced the world's first handheld, single-probe, whole-body ultrasound system. Since then, the device has been used by tens of thousands of medical professionals across the globe with significant clinical, economic and societal impact,” said Laurent Faracci, Butterfly Network’s CEO. “We have collaborated with the Butterfly community of users to define our innovation path. The first result in that journey is the new Butterfly iQ+, a big step forward for point-of-care ultrasound, with our most advanced chip ever and a number of amazing innovations and improvements that our talented team and partners developed.”

Butterfly iQ+ features an optimized manufacturing process in partnership with TSMC, the largest and most advanced dedicated IC foundry in the world. TSMC’s MEMS (microelectromechanical systems) manufacturing technology enables the ultrasound transducer to seamlessly integrate with CMOS (complementary metal-oxide semiconductor) technology. In addition, TSMC possesses manufacturing capacity that can scale to realize Butterfly’s vision of making an ultrasound device as ubiquitous as the stethoscope for the world’s 40 million healthcare providers, the company said.

Butterfly’s innovative product has been shown to be a particularly useful tool during the global COVID-19 (SARS-CoV-2) pandemic due to its lung imaging capabilities, portability and ease of cleaning, as infection control has become increasingly important. Butterfly iQ+ brings a suite of new capabilities that make it even easier to make fast decisions at the bedside. 

“These new capabilities bring us one step closer to realizing the full potential of bedside point-of-care ultrasound as the stethoscope of the future, a true window into the body,” said Dr. John Martin, Butterfly Network’s chief medical officer. 

 

Butterfly iQ+ Offers Faster, Sharper Imaging

With patented on-chip digital micro-beamforming enabling 15% faster frame rates and 60% faster pulse repetition frequency, healthcare providers can see image details in the heart, lungs and bladder with optimized clarity. High-performance shallow imaging capabilities help support fast, confident interventional decision-making, while deep imaging capabilities in the lung and deep cardiac presets allow for sharp details. The Butterfly iQ+ can help healthcare providers save time in their diagnosis and treatment of patients, improving overall patient outcomes.

 

State-of-the-art POCUS Technology Offers New Levels of Control

The cutting-edge Needle Viz technology available on Butterfly iQ+ can provide healthcare professionals with an enhanced ability to see a needle—improving confidence for central line placements, regional nerve blocks and other guided procedures. Additionally, in just four seconds, clinicians can calculate bladder volume automatically using the AI-based Auto Bladder Volume tool, allowing faster decisions at the bedside. 

 

Hand-held Ultrasound Offers More Power and Durability 

The Butterfly iQ+ extends battery life by 20% and scanning time by 100% to help healthcare providers get through their shift. With its durable, anodized aluminum body and replaceable compression- and stomp-tested cable, the Butterfly iQ+ offers military-grade durability to withstand tough shifts, and has been tested to withstand an industry-leading 4-foot drop. This next-generation device has gone through rigorous testing to ensure shock resistance and protection from dust and water damage. 

For more information: www.butterflynetwork.com


Related Content

Videos | Cardiac Imaging

Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val ...

Home January 23, 2023
Home
News | Cardiac Imaging

January 13, 2023 — Nuclear stress testing performed with single-photon emission computed tomography (SPECT) is the most ...

Home January 13, 2023
Home
News | Cardiac Imaging

November 29, 2022 — Researchers have developed a deep learning model that uses a single chest X-ray to predict the 10 ...

Home November 29, 2022
Home
News | Cardiac Imaging

November 28, 2022 – UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power ...

Home November 28, 2022
Home
News | Cardiac Imaging

November 28, 2022 — Konica Minolta Healthcare Americas, Inc., a leader in medical diagnostic imaging and healthcare ...

Home November 28, 2022
Home
Feature | Cardiac Imaging

Discover the key features of cardiovascular structured reporting that drive adoption, including automated data flow, EHR ...

Home November 07, 2022
Home
News | Cardiac Imaging

October 18, 2022 — HeartFlow, Inc., a leader in revolutionizing precision heart care, has received U.S. Food and Drug ...

Home October 18, 2022
Home
Webinar | Cardiac Imaging

The direct impact of COVID-19 is substantial. The resulting impact of the pandemic has forced healthcare organizations ...

Home October 17, 2022
Home
News | Cardiac Imaging

October 11, 2022 — Researchers from the University of Minnesota Medical School found that patients with certain features ...

Home October 11, 2022
Home
News | Cardiac Imaging

September 2, 2022 — A randomized trial in more than 45,000 men has suggested that cardiovascular screening including ...

Home September 02, 2022
Home
Subscribe Now